2024 MRinRT

It’s been two intensive days so far at the Fondazione Policlinico Universitario Agostino Gemelli IRCCS #MRinRT2024 symposium tomorrow friday April 5th will be the last day of the symposium , various discussions revolving about the role of MRIgRT in the treatment of different types of cancers and new paradigm shifts being made by AI are being presented by researchers, Medical Doctors, scientists and different speakers . #MRIgRT #AI #Radiotherapy #Oncology #Cancer 

Thanks to Università Cattolica del Sacro Cuore , Gemelli ART and other collaborators for the invitation and great hospitality 😊.

Lucky Kabejae
TSRM Gruppo San Donato, Milan

Always very proud to present results of the MOMENTUM study; this time about quality of life and toxicity in patients with pancreatic ductal adenocarcinoma at the #MRinRT2024 conference in Rome

The unique global MOMENTUM collaboration gives us the opportunity to study outcomes after MR-guided radiotherapy in a large, international, prospective patient cohort, enabling evidence-based implementation of the 1.5T MR-Linac according to the R-IDEAL framework. 

Ablative stereotactic MR-guided online adaptive radiation therapy is particularly promising for patients with mobile abdominal tumors, such as pancreatic cancer. We will investigate the impact of MR-guided radiotherapy on health related quality of life and survival in patients with locally advanced pancreatic cancer in the Dutch randomized #LAPSTAR trial (funded by KWF Kankerbestrijding) - which is expected to start enrolling patients in the upcoming weeks! 

Jasmijn Westerhoff HM (Lenny) Verkooijen Martijn Intven Jacobien Scheepens William A. Hall, MD Anna Bruynzeel #DPCG Cancer Research UMC Utrecht UMC Utrecht

Lois Daamen
Assistant Professor, UMC Utrecht & DPCG | Clinical Epidemiologist | Focused on Clinical & Technical Innovations in Cancer Research